nifedipine brands

21 registered brands containing nifedipine in Malawi.

Nifedipine

PubChem CID 4485

Molecular formula: C17H18N2O6

Nifedipine blocks voltage gated L-type calcium channels in vascular smooth muscle and myocardial cells. This blockage prevents the entry of calcium ions into cells during depolarization, reducing peripheral arterial vascular resistance and dilating coronary arteries. These actions reduce blood pressure and increase the supply of oxygen to the heart, alleviating angina. The principal physiologic action of nifedipine is to inhibit the transmembrane influx of extracellular calcium ions across the membranes of myocardial cells and vascular smooth muscle cells, without changing serum calcium concentrations. Calcium plays important roles in the excitation-contraction coupling processes of the heart and vascular smooth muscle cells and in the electrical discharge of the specialized conduction cells of the heart. The membranes of these cells contain numerous channels that carry a slow inward current and that are selective for calcium. Activation of these slow calcium channels contributes to the plateau phase (phase 2) of the action potential of cardiac and vascular smooth muscle cells. The exact mechanism whereby nifedipine inhibits calcium ion influx across the slow calcium channels is not known, but the drug is thought to inhibit ion-control gating mechanisms of the channel, deform the slow channel, and/or interfere with release of calcium from the sarcoplasmic reticulum. By inhibiting calcium influx, nifedipine inhibits the contractile processes of cardiac and vascular smooth muscle, thereby dilating the main coronary and systemic arteries. Nifedipine is a peripheral arterial vasodilator which acts directly on vascular smooth muscle. The binding of nifedipine to voltage-dependent and possibly receptor-operated channels in vascular smooth muscle results in an inhibition of calcium influx through these channels. Stores of intracellular calcium in vascular smooth muscle are limited and thus dependent upon the influx of extracellular calcium for contraction to occur. The reduction in calcium influx by nifedipine causes arterial vasodilation and decreased peripheral vascular resistance which results in reduced arterial blood pressure.

Source: PubChem (NCBI) ยท compound 4485

Product Manufacturer Status Country
ADCO VASCARD SR 20 20MG TABLET
TABLET
- Registered Malawi
CALCIGARD 20MG TABLETS
TABLETS
- Registered Malawi
FENAMON-SR 20MG TABLET
TABLET
- Registered Malawi
NICARDIA 10MG SOFT GELATIN CAPSULE
SOFT GELATIN CAPSULE
- Registered Malawi
NICARDIA 20MG SUSTAINED RELEASE TABLET
SUSTAINED RELEASE TABLET
- Registered Malawi
NIFECOR-20 20MG TABLET
TABLET
- Registered Malawi
NIFEDIPINE 10MG TABLET
TABLET
- Registered Malawi
NIFEDIPINE 10MG TABLET
TABLET
- Registered Malawi
NIFEDIPINE-DENK-10 10 MG RETARD TABLET
RETARD TABLET
- Registered Malawi
NIFEDIPINE-DENK 20 20 MG RETARD TABLET
RETARD TABLET
- Registered Malawi
NIFEDIPINE-RETARD 20MG TABLET
TABLET
- Registered Malawi
NIFEGARD-20-SR 20MG TABLET
TABLET
- Registered Malawi
NIFELAT 10MG TABLET
TABLET
- Registered Malawi
NIFELAT 20MG SUSTAINED RELEASE TABLET
SUSTAINED RELEASE TABLET
- Registered Malawi
NIFELAT RETARD 20MG TABLET
TABLET
- Registered Malawi
NIFINE 20MG SLOW RELEASE TABLETS
SLOW RELEASE TABLETS
- Registered Malawi
NIPINE-10 10MG TABLET
TABLET
- Registered Malawi
NIPINE-SR 20MG TABLET
TABLET
- Registered Malawi
NIPINE 10 10MG TABLET
TABLET
- Registered Malawi
NIPINE SR 20MG TABLET
TABLET
- Registered Malawi
OKA-NIFEDIPINE 20MG SLOW RELEASE TABLET
SLOW RELEASE TABLET
- Registered Malawi